Neurological manifestations of neurofibromatosis: a review

被引:14
作者
Bayat, Michael [1 ,2 ]
Bayat, Allan [3 ]
机构
[1] Aarhus Univ Hosp, Dept Neurol, Aarhus, Denmark
[2] Aarhus Univ Hosp, Ctr Rare Dis, Aarhus, Denmark
[3] Danish Epilepsy Ctr, Dianalund, Denmark
关键词
Neurofibromatosis; Neuropathy; Cerebrovascular disorders; Epilepsy; Neoplasms; Headache; UNIDENTIFIED BRIGHT OBJECTS; CENTRAL-NERVOUS-SYSTEM; CLINICAL PRESENTATION; CNS TUMORS; TYPE-1; CHILDREN; EPILEPSY; GLIOMAS; INDIVIDUALS; PREVALENCE;
D O I
10.1007/s10072-020-04400-x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Neurofibromatosis type 1(NF1) is a dominantly inherited genetic disorder caused by a mutation in the NF1 tumor-suppressor gene. Patients are prone to develop benign and malignant tumors not only in the central and peripheral nervous system but also in other parts of the body. Apart from tumors, neurofibromatosis may also be associated with neurological symptoms and disorders such as cerebrovascular disease, epilepsy, neuropathy, and headache. This article seeks to review the different neurological manifestations of neurofibromatosis.
引用
收藏
页码:2685 / 2690
页数:6
相关论文
共 43 条
  • [1] Prevalence and clinical presentation of headache in a National Neurofibromatosis 1 Service and impact on quality of life
    Afridi, Shazia K.
    Leschziner, Guy D.
    Ferner, Rosalie E.
    [J]. AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2015, 167 (10) : 2282 - 2285
  • [2] Novel epidemiological features of moyamoya disease
    Baba, T.
    Houkin, K.
    Kuroda, S.
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2008, 79 (08) : 900 - 904
  • [3] Epilepsy surgery in Neurofibromatosis Type 1
    Barba, Carmen
    Jacques, Thomas
    Kahane, Philippe
    Polster, Tilman
    Isnard, Jean
    Leijten, Frans S. S.
    Ozkara, Cigdem
    Tassi, Laura
    Giordano, Flavio
    Castagna, Maura
    John, Alison
    Oz, Buge
    Salon, Caroline
    Streichenberger, Nathalie
    Cross, Judith Helen
    Guerrini, Renzo
    [J]. EPILEPSY RESEARCH, 2013, 105 (03) : 384 - 395
  • [4] Clinical presentation and prognostic indicators in 100 adults and children with neurofibromatosis 1 associated non-optic pathway brain gliomas
    Byrne, Susan
    Connor, Steve
    Lascelles, Karine
    Siddiqui, Ata
    Hargrave, Darren
    Ferner, Rosalie E.
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2017, 133 (03) : 609 - 614
  • [5] Cerebrovascular dysplasia in neurofibromatosis type 1
    Cairns, A. G.
    North, K. N.
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2008, 79 (10) : 1165 - 1170
  • [6] CNS Tumors in Neurofibromatosis
    Campian, Jian
    Gutmann, David H.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (21) : 2378 - +
  • [7] Headache in patients with neurofibromatosis type 1
    Clementi, M
    Battistella, PA
    Rizzi, L
    Boni, S
    Tenconi, R
    [J]. HEADACHE, 1996, 36 (01): : 10 - 13
  • [8] Neurological complications of neurofibromatosis type 1 in adulthood
    Créange, A
    Zeller, J
    Rostaing-Rigattieri, S
    Brugières, P
    Degos, JD
    Revuz, J
    Wolkenstein, P
    [J]. BRAIN, 1999, 122 : 473 - 481
  • [9] Medullary unidentified bright objects in Neurofibromatosis type 1: a case series
    D'Amico, Alessandra
    Mazio, Federica
    Ugga, Lorenzo
    Cuocolo, Renato
    Cirillo, Mario
    Santoro, Claudia
    Perrotta, Silverio
    Melis, Daniela
    Brunetti, Arturo
    [J]. BMC PEDIATRICS, 2018, 18
  • [10] Use of "unidentified bright objects" on MRI for diagnosis of neurofibromatosis 1 in children
    DeBella, K
    Poskitt, K
    Szudek, J
    Friedman, JM
    [J]. NEUROLOGY, 2000, 54 (08) : 1646 - 1650